# Claude Commander: High-Value Use Cases
## General-Purpose Parallel Data Analysis and Intelligence Platform

This document describes the highest-value use cases for Claude Commander as it expands beyond programming assistance into a general-purpose parallel intelligence platform. Each use case exploits the same core architectural advantage: simultaneous multi-agent analysis with cross-document synthesis — the thing no single model and no human team can do at comparable speed and cost.

---

## Table of Contents

1. [Pharmaceutical Regulatory Submission Analysis](#use-case-1-pharmaceutical-regulatory-submission-analysis)
2. [Legal Discovery and Document Review](#use-case-2-legal-discovery-and-document-review)
3. [M&A Due Diligence](#use-case-3-ma-due-diligence)
4. [Prediction Market Intelligence](#use-case-4-prediction-market-intelligence)
5. [Competitive Intelligence at Scale](#use-case-5-competitive-intelligence-at-scale)
6. [SEM Sentinel Integration (Parallel SEM Audit)](#use-case-6-sem-sentinel-integration-parallel-sem-audit)
7. [Medical/Pharma Literature Synthesis](#use-case-7-medicalpharma-literature-synthesis)
8. [Options & Quantitative Trading](#use-case-8-options--quantitative-trading)
9. [Priority Ranking](#priority-ranking)

---

## USE CASE 1: Pharmaceutical Regulatory Submission Analysis

**What it is:** Parallel analysis of 100,000–500,000 page drug approval submissions (NDA/BLA/MAA) across FDA, EMA, and PMDA jurisdictions to identify cross-reference gaps, CMC deficiencies, and cross-jurisdiction conflicts before submission.

### The Parallel Advantage

A single AI cannot simultaneously hold a preclinical toxicology finding, its reference in a clinical study report, the corresponding label claim, and the divergent requirements of three regulatory agencies. Sequential analysis misses cross-document inconsistencies — which cause 74% of FDA Complete Response Letters (rejections). Parallel analysis with synthesis catches them.

### Agent Architecture

```
CTO Agent (Opus) — cross-jurisdiction strategy
├── FDA Orchestrator
│   ├── Module 2 workers (4) — summaries, consistency
│   ├── Module 3 workers (8) — CMC, manufacturing, stability
│   ├── Module 4 workers (6) — nonclinical by study type
│   ├── Module 5 workers (20) — clinical study reports by phase
│   └── Cross-reference workers (6) — trace references across modules
├── EMA Orchestrator
│   ├── Same domain workers reading FDA outputs as context
│   └── Divergence workers — where EMA differs from FDA
├── PMDA Orchestrator
│   └── Japan-specific adaptation workers
└── Cross-Jurisdiction Synthesis
    ├── Conflict identification (6 workers)
    ├── Strategy resolution (4 workers)
    └── Label harmonization (4 workers)
```

Total: ~60 agents active simultaneously

### Input Data

- eCTD modules 1–5 (PDF, XML)
- Clinical study reports
- Manufacturing batch records
- Labeling drafts
- Regulatory guidance documents (FDA, EMA, PMDA)

### Output Deliverables

- Cross-reference gap report (missing or broken references between modules, with document and page citations)
- CMC deficiency analysis (specific gaps against agency expectations)
- Cross-jurisdiction conflict matrix (FDA vs. EMA vs. PMDA requirements, side by side)
- Label claim traceability table (each claim mapped to supporting data table mapped to study report)
- Pre-submission risk score with prioritized recommendations

### Revenue Model

| Customer Type | Price Range |
|---|---|
| Series A/B biotechs | $25,000–$75,000 per regulatory intelligence package |
| Mid-size pharma | $100,000–$250,000 per major submission analysis |
| Multi-jurisdiction (FDA + EMA + PMDA) | $400,000–$800,000 per submission |

Target: 10–15 engagements per year at an average of $150K = $1.5–2.25M ARR

### Human vs. AI Comparison

| Metric | Human Team | Claude Commander |
|---|---|---|
| Team size | 25–120 specialists | 1–2 domain experts + system |
| Timeline | 16–36 months | 4–16 weeks |
| Cost | $8M–$60M | $150K–$800K |
| Pages reviewed per day | ~800 | ~15,000–25,000 |
| Cross-reference detection | Sequential over months | Simultaneous over weeks |

### Scenario Complexity Tiers

**Tier 1: Standard NDA (Small Molecule, One Indication)**
- 85,000–200,000 pages, 4–6 weeks, $150–300K
- ~50 agents active simultaneously

**Tier 2: Complex BLA (Biologic, Rare Disease)**
- 100,000–200,000+ pages with highest cross-reference density
- 200+ critical quality attributes each with specification, method, and validation data
- Comparability studies: 8 workers simultaneously, each holding one lot-to-lot comparison
- Surrogate endpoint evidence chains spanning 15,000 pages across 6 study reports
- Biomarker validation chain: Module 4 → Module 5.3 → pivotal study → proposed label
- 6–10 weeks, $200–500K, ~60 agents

**Tier 3: Simultaneous Multi-Jurisdiction (FDA + EMA + PMDA)**
- 240,000–500,000 pages combined across three regulatory frameworks
- Three different languages (English, EU-English conventions, Japanese)
- FDA flexible case-specific model vs. EMA structured risk-tiered approach
- Endpoint divergence: FDA may accept OS, EMA may require QoL co-primary, PMDA needs bridging data
- Architecture: FDA team (orchestrator → 15 workers → 60 subagents), EMA team (12 workers → 48 subagents), PMDA team (10 workers → 40 subagents), plus cross-jurisdiction synthesis team
- 10–16 weeks, $400–800K, ~148 agents

### Pre-Trial Application (Highest-Value Product)

The most valuable application of the multi-jurisdiction system is BEFORE the trial is designed, not after. A biotech company needs to know what endpoints FDA, EMA, and PMDA each require BEFORE designing their pivotal trial. The system runs the cross-jurisdiction divergence analysis pre-trial so the company designs ONE trial that satisfies all three agencies simultaneously.

This is the product with the highest ROI anchor: at $500K–1.5M per day of approval on a major oncology product, collapsing a 24-month gap into a 12-week analysis is worth more than the entire engagement fee many times over.

**FDA Elsa AI angle:** The FDA deployed Elsa, an agency-wide AI assistant, in June 2025. Elsa summarizes adverse event trends, compares product labels, and identifies inconsistencies across submissions. The product pitch: "The FDA is now using agentic AI to review your submission. We use the same class of system to analyze your submission before it reaches them, so you're not surprised by what they find."

---

## USE CASE 2: Legal Discovery and Document Review

**What it is:** Parallel analysis of large document sets (10,000–500,000 documents) for litigation, producing privilege logs, issue coding, hot document identification, and thematic analysis.

### The Parallel Advantage

Document A only becomes relevant in light of Document B. Sequential review misses these connections. A human team of 50 contract reviewers coordinates poorly via Excel trackers. Parallel agents with a synthesis layer surface cross-document patterns — communication chains, contradictions, entity co-occurrence — that sequential review misses entirely.

### Agent Architecture

```
CTO Agent (Opus) — case strategy, issue framework
├── Privilege Review Orchestrator
│   └── 20 privilege workers (each assigned a batch of documents)
├── Issue Coding Orchestrator
│   ├── Issue-1 workers — e.g., "fraud awareness"
│   ├── Issue-2 workers — e.g., "regulatory compliance"
│   └── Issue-N workers (one per litigation issue)
├── Hot Document Orchestrator
│   └── 10 relevance-scoring workers
├── Timeline Reconstruction Orchestrator
│   └── 8 chronology workers (date-sorted document batches)
└── Cross-Document Pattern Synthesis
    ├── Entity co-occurrence workers
    ├── Communication chain trackers
    └── Contradiction and inconsistency detectors
```

### Input Data

- Email archives (PST, MBOX)
- PDFs and Word documents
- Spreadsheets
- Slack and chat exports
- Financial records
- Deposition transcripts

### Output Deliverables

- Privilege log (document, privilege type, basis, review status)
- Issue coding matrix (document × issue with relevance scores)
- Hot document report (ranked by relevance with supporting excerpts)
- Timeline of events with source citations
- Key custodian analysis (who knew what, when)

### Revenue Model

| Customer Type | Price Range |
|---|---|
| Per-matter review | $50,000–$200,000 depending on document volume |
| Monthly retainer (ongoing litigation) | $15,000–$30,000 per month |

Target: 20–30 matters per year at an average of $75K = $1.5–2.25M ARR

### Human vs. AI Comparison

| Metric | Human Team | Claude Commander |
|---|---|---|
| Team size | 20–50 contract reviewers + 3–5 attorneys | 1–2 attorneys + system |
| Timeline | 4–12 weeks | 3–7 days |
| Cost | $500K–$2M per review | $50K–$200K |
| Documents reviewed per day | ~200 per reviewer | ~5,000–10,000 total |
| Cross-document pattern detection | Rarely achieved | Systematic |

---

## USE CASE 3: M&A Due Diligence

**What it is:** Parallel analysis of target company documents across financial, legal, IP, employment, regulatory, and competitive dimensions for acquisition evaluation.

### The Parallel Advantage

Due diligence workstreams are genuinely parallel — financials, contracts, IP, employment, regulatory compliance, and competitive positioning can all be analyzed simultaneously. A 10-person team coordinates poorly over 6–8 weeks and frequently misses cross-domain risks. The system runs all workstreams at once and cross-references findings across domains (e.g., an employment agreement that creates an IP assignment risk that materially affects valuation).

### Agent Architecture

```
CTO Agent (Opus) — deal evaluation, risk synthesis
├── Financial Analysis Orchestrator
│   ├── Revenue workers (3) — recognition, trends, concentration
│   ├── Cost workers (3) — COGS, SG&A, unusual items
│   └── Cash flow workers (2) — working capital, capex
├── Legal Analysis Orchestrator
│   ├── Contract workers (6) — material agreements, change-of-control clauses
│   ├── Litigation workers (3) — pending, threatened, historical
│   └── Regulatory workers (2) — compliance status, permits, violations
├── IP Analysis Orchestrator
│   ├── Patent workers (3) — portfolio strength, freedom to operate
│   ├── Trade secret workers (2) — protection measures, employee access
│   └── Assignment workers (2) — chain of title, employee IP agreements
├── Employment Orchestrator
│   ├── Key person workers (2) — retention risk, non-compete enforceability
│   ├── Benefits workers (2) — liabilities, change-of-control triggers
│   └── Culture workers (1) — Glassdoor and review corpus analysis
└── Cross-Domain Risk Synthesis
    ├── Deal-breaker identification workers
    ├── Valuation impact workers
    └── Integration risk workers
```

### Input Data

- Financial statements and management accounts
- Material contracts and vendor agreements
- Patent filings and IP assignments
- Employee records, offer letters, and non-compete agreements
- Litigation dockets and correspondence
- Regulatory filings and compliance records
- Customer contracts and churn data

### Output Deliverables

- Risk matrix (risk × severity × probability × estimated financial impact)
- Deal-breaker report (issues that should halt or restructure the transaction)
- Valuation adjustment analysis (how specific findings affect the offer price)
- Integration risk assessment
- 100-day post-close plan recommendations

### Revenue Model

| Customer Type | Price Range |
|---|---|
| Standard per-deal package | $75,000–$150,000 |
| Accelerated timeline premium (under 2 weeks) | +25% |

Target: 15–25 deals per year at an average of $100K = $1.5–2.5M ARR

### Human vs. AI Comparison

| Metric | Human Team | Claude Commander |
|---|---|---|
| Team size | 10–20 specialists | 2–3 domain experts + system |
| Timeline | 6–8 weeks | 4–7 days |
| Cost | $250K–$500K | $75K–$150K |
| Cross-domain risk detection | Manual coordination, frequently missed | Systematic cross-referencing |

---

## USE CASE 4: Prediction Market Intelligence

**What it is:** Multi-source parallel research and probability estimation for prediction market trading (Kalshi, Polymarket, Manifold), producing actionable probability estimates compared to current market prices.

### The Parallel Advantage

Most prediction market traders use a single model evaluating one information source at a time. The system runs 20+ parallel research threads across news, social sentiment, historical base rates, regulatory filings, domain expert analysis, and quantitative modeling — then synthesizes into a probability estimate with confidence intervals. Breadth and speed of research are the edge.

### Agent Architecture

```
CTO Agent (Opus) — portfolio strategy, position sizing
├── Market Scanner Orchestrator
│   └── 5 market monitoring workers (scan for mispriced contracts)
├── Research Orchestrator (per question)
│   ├── News workers (3) — current coverage, source credibility weighting
│   ├── Sentiment workers (2) — social media, expert opinion aggregation
│   ├── Base rate workers (2) — historical precedent analysis
│   ├── Domain workers (3) — regulatory, political, economic context
│   └── Statistical workers (2) — quantitative modeling
└── Synthesis and Trading Orchestrator
    ├── Probability estimation workers
    ├── Edge calculation workers (AI estimate vs. market price)
    └── Position sizing workers (Kelly criterion, risk limits)
```

### Input Data

- News APIs (Reuters, AP, specialty outlets)
- Social media feeds (X, Reddit, niche forums)
- Regulatory filing databases
- Historical resolution data from past contracts
- Financial and economic data
- Political event databases and polling aggregators

### Output Deliverables

- Probability estimates with confidence intervals for each contract
- Edge report (contracts where market price diverges from estimated probability by more than the threshold)
- Position recommendations with size limits per contract
- Research audit trail (how each source influenced the probability estimate)

### Revenue Model

| Revenue Stream | Range |
|---|---|
| Proprietary trading on $100K–$1M book | Target 15–30% annual return |
| Signal subscription service | $500–$2,000 per month |
| Institutional portfolio intelligence | $5,000–$10,000 per month |

Target: Trading profits plus 50–100 subscribers at $1K/month = $50–100K per month

---

## USE CASE 5: Competitive Intelligence at Scale

**What it is:** Continuous monitoring of 100–500 competitors simultaneously — tracking pricing changes, job postings, patent filings, regulatory submissions, customer reviews, and partner announcements — with daily synthesized intelligence briefs and anomaly detection.

### The Parallel Advantage

No human team can monitor 500 companies daily. A sequential AI cannot stay current across that breadth. The system assigns dedicated worker clusters to company groups, runs daily collection subagents, and routes meaningful signal up the hierarchy. Coverage breadth at maintained depth is the differentiator.

### Agent Architecture

```
CTO Agent (Opus) — strategic assessment, priority ranking
├── Company Cluster Orchestrators (10, each owns 50 companies)
│   ├── Pricing monitor workers (2 per cluster)
│   ├── Job posting workers (2 per cluster) — hiring reveals strategy
│   ├── Patent and filing workers (1 per cluster)
│   ├── Review and sentiment workers (1 per cluster)
│   └── News and announcement workers (1 per cluster)
├── Cross-Company Synthesis Orchestrator
│   ├── Trend identification workers
│   ├── Anomaly detection workers
│   └── Market shift workers
└── Intelligence Delivery Orchestrator
    ├── Daily brief generator
    ├── Alert workers (significant events, real-time)
    └── Weekly deep-dive report generator
```

### Input Data

- Company websites (pricing pages, product pages, changelog)
- Job boards (LinkedIn, Greenhouse, Lever, Workable)
- Patent databases (USPTO, EPO)
- App store reviews (Apple App Store, Google Play)
- News APIs and press release feeds
- SEC filings and regulatory databases
- Social media and community forums

### Output Deliverables

- Daily intelligence brief (1–2 pages, key signals only, noise filtered out)
- Anomaly alerts (real-time notification when a significant event is detected)
- Weekly deep-dive report (trends, strategy shifts, market movements)
- Competitive positioning matrix (updated weekly with source citations)

### Revenue Model

| Customer Type | Monthly Price |
|---|---|
| SMB (up to 50 competitors) | $3,000–$5,000 per month |
| Mid-market (up to 200 competitors) | $5,000–$10,000 per month |
| Enterprise (500+ competitors) | $15,000–$30,000 per month |

Target: 30–50 clients at an average of $5K/month = $150–250K per month = $1.8–3M ARR

---

## USE CASE 6: SEM Sentinel Integration (Parallel SEM Audit)

**What it is:** Integration with the existing SEM Sentinel product to run its backward analysis agents (Waste Hunter, Cannibal Detector, Trend Analyst, and others) in parallel across multiple accounts simultaneously, and to power the forward intelligence layer with parallel research.

### The Parallel Advantage

SEM Sentinel currently runs agents sequentially on one account at a time. Claude Commander enables three step-changes: (1) all backward analysis agents running simultaneously on the same account — waste detection, cannibalization, trends, PMax audit, and opportunity mapping completing in parallel rather than in sequence; (2) multiple client accounts analyzed simultaneously for agencies; (3) cross-account intelligence for multi-brand companies that is not possible with sequential analysis.

### Agent Architecture

```
CTO Agent (Opus) — cross-account strategy
├── Account Orchestrators (1 per client account)
│   ├── Waste Hunter worker — zero-conversion spend identification
│   ├── Cannibal Detector worker — cross-campaign keyword overlap
│   ├── Trend Analyst worker — historical performance patterns
│   ├── PMax Auditor worker — Smart Bidding verification
│   ├── Opportunity Mapper worker — missed keyword discovery
│   └── Decision Differ worker — historical decision audit
├── Cross-Account Synthesis (for multi-brand and agency clients)
│   ├── Cross-brand intelligence workers
│   ├── Industry benchmark workers
│   └── Agency-level optimization workers
└── Forward Intelligence Orchestrator
    ├── Seasonal prediction workers (parallel research per market segment)
    ├── Competitive tracker workers (monitor competitor ad strategies)
    └── Retest queue workers (prioritize dropped keywords for reactivation)
```

### Input Data

- Google Ads API data (search terms, campaigns, ad groups, performance metrics)
- Historical CSV exports
- CRM and billing data for LTV-weighted analysis

### Output Deliverables

- Unified audit report across all backward agents (deduplicated findings, no double-counting)
- Cross-account cannibalization report (for multi-brand and agency clients)
- Seasonal intelligence calendar with reactivation recommendations
- CFO-ready financial impact report (wasted spend recovered, projected lift)
- PPC team technical recommendations report (implementation-ready)

### Revenue Model

- Same tier structure as existing SEM Sentinel pricing, with parallel speed as the premium differentiator
- Agency tier captures the most value: 10+ accounts audited overnight instead of sequentially over days
- Cross-account intelligence is a premium add-on ($500/month)
- Strategic impact: accelerates SEM Sentinel to market, improves margin per audit, enables agency-scale contracts previously not serviceable

### Integration Specifics

- Claude Commander template `sem-audit` creates workers that map directly to SEM Sentinel's Layer 1 agent definitions
- Document ingestion layer handles CSV and API data instead of PDFs — same orchestration model, different input format
- Output schemas match SEM Sentinel's finding schema (`finding_id`, `severity`, `evidence_chain`, `dollar_impact`)
- SEM Sentinel's dashboard consumes Claude Commander's structured output via API — no UI changes required
- Cross-reference engine detects keyword cannibalization across campaigns and across accounts in a single pass

### Human vs. AI Comparison (Single Account, $100K/Month Spend)

| Metric | Manual Consultant | Sequential SEM Sentinel | Parallel (CC-Powered) |
|---|---|---|---|
| Time to full audit | 4–6 hours | 15–30 minutes | 3–5 minutes |
| Cross-campaign analysis | Manual, often missed | Sequential, ~10 min | Parallel, ~1 min |
| 10-account agency audit | 40–60 hours | 2.5–5 hours | 30–50 minutes |
| Cross-account intelligence | Rarely done | Not yet built | Built-in |

---

## USE CASE 7: Medical/Pharma Literature Synthesis

**What it is:** Parallel analysis of 10,000+ medical/scientific papers across therapeutic areas to produce structured evidence summaries with confidence ratings for regulatory submissions, clinical protocol development, and formulary decisions.

### The Parallel Advantage

Literature reviews touch 10,000+ papers that reference each other. Sequential analysis misses cross-paper patterns. Parallel synthesis with a hierarchical review layer catches connections between papers in different therapeutic areas, contradictory findings across studies, and evolving evidence trends that no single-paper reading can surface.

### Agent Architecture

```
CTO Agent (Opus) — evidence synthesis strategy
├── Therapeutic Area Orchestrators (1 per area)
│   ├── Paper batch workers (5-10 per area) — read and summarize papers
│   ├── Methodology assessment workers (2) — evaluate study quality, bias risk
│   └── Statistical extraction workers (2) — extract endpoints, p-values, effect sizes
├── Cross-Paper Synthesis Orchestrator
│   ├── Contradiction detection workers (3) — find conflicting findings across papers
│   ├── Evidence chain workers (4) — trace citation chains through the literature
│   └── Gap identification workers (2) — what questions remain unanswered
└── Regulatory Documentation Orchestrator
    ├── Evidence grading workers (2) — GRADE framework scoring
    ├── Methodology documentation workers (2) — FDA-required rigor documentation
    └── Summary generation workers (2) — structured evidence tables
```

### Input Data

- PubMed abstracts and full-text papers
- Cochrane reviews
- Clinical trial registries (ClinicalTrials.gov)
- FDA guidance documents
- Systematic review databases

### Output Deliverables

- Structured evidence summary with confidence ratings per finding
- Evidence grading table (GRADE framework)
- Cross-paper contradiction report
- Citation chain analysis (which papers cite which, strength of evidence flow)
- Gap analysis (unanswered questions, needed studies)
- FDA-compliant methodology documentation (the RESULT.md → SUMMARY.md → SYNTHESIS.md audit trail satisfies FDA documentation requirements)

### Revenue Model

- Per literature review: $50,000–$150,000
- Ongoing monitoring retainer: $10,000–$20,000/month
- Target: 15–20 reviews/year at average $80K = $1.2–1.6M ARR

### Human vs. AI Comparison

| Metric | Human Team | Claude Commander |
|--------|-----------|-----------------|
| Team size | 8–15 researchers + statistician | 1–2 domain experts + system |
| Timeline | 6–12 months | 2–4 weeks |
| Cost | $200,000–$500,000 | $50,000–$150,000 |
| Papers analyzed/day | 20–30 per researcher | 500–1,000 |
| Cross-paper patterns | Rarely detected systematically | Systematic contradiction/chain analysis |

---

## USE CASE 8: Options & Quantitative Trading

**What it is:** Parallel multi-factor analysis for options trading, simultaneously modeling outcome scenarios, analyzing options flow sentiment, comparing implied vs. historical volatility, checking insider trading filings, and synthesizing analyst estimate dispersions — with an edge in the 15-minute to 24-hour "reasoned position" window where fundamental synthesis matters more than execution speed.

### The Parallel Advantage

Options pricing on less-liquid names around specific catalysts is often inefficient because the synthesis work required to price correctly is prohibitive. Running 20+ parallel analysis threads covering heterogeneous signals (technical, fundamental, sentiment, regulatory, insider activity) and synthesizing them into a position recommendation is what creates the edge. This is not high-frequency trading — it's the "reasoned position" tier.

### Agent Architecture

```
CTO Agent (Opus) — portfolio strategy, HARD risk limits (position sizing, max drawdown, sector exposure caps)
│   [Risk management is a HARD CONSTRAINT at CTO level — workers CANNOT override]
├── Scenario Modeling Orchestrator
│   ├── Outcome scenario workers (5-10) — model different event outcomes and option payoffs
│   ├── Implied vs historical vol workers (2) — vol surface analysis, term structure
│   └── Greeks sensitivity workers (2) — delta/gamma/vega/theta exposure mapping
├── Signal Research Orchestrator
│   ├── Options flow workers (3) — unusual activity, dark pool prints, sweep detection
│   ├── Insider filing workers (2) — Form 4 analysis, cluster buying/selling
│   ├── Analyst estimate workers (2) — dispersion analysis, revision momentum
│   ├── News/catalyst workers (3) — event timeline, regulatory dates, earnings
│   └── Social sentiment workers (2) — retail positioning, wallstreetbets, fintwit
├── Backtesting Orchestrator
│   ├── Historical replay workers (4) — test strategy against past similar setups
│   ├── Statistical validation workers (2) — Sharpe, Sortino, max drawdown, win rate
│   └── Regime comparison workers (2) — current environment vs historical analogs
└── Execution Orchestrator
    ├── Structure optimization workers (2) — optimal spread/structure for thesis
    ├── Entry timing workers (2) — liquidity windows, bid-ask analysis
    └── Position sizing workers (1) — Kelly criterion with risk-adjusted sizing
```

### Input Data

- Options chains (via brokerage API — Interactive Brokers, Alpaca, Tastytrade)
- SEC EDGAR filings (Form 4, 13F)
- Market data feeds
- Earnings calendars
- News APIs
- Social sentiment feeds

### Output Deliverables

- Probability-weighted scenario analysis with option payoffs per scenario
- Signal consensus report (agreement/disagreement across all research threads)
- Backtested strategy performance (Sharpe, Sortino, max drawdown, win rate)
- Specific trade recommendation (structure, strikes, expiry, size, entry price, stop loss)
- Risk report (portfolio Greeks, correlation exposure, worst-case scenario)

### Revenue Model

- Self-use: trading profits on $100K–$1M book (target 15–30% annual returns)
- Signal service: $2,000–$5,000/month subscription for institutional-grade analysis
- Target: trading profits + 20–50 subscribers at $3K = $60–150K/month

### Human vs. AI Comparison

| Metric | Human Trader/Analyst | Claude Commander |
|--------|---------------------|-----------------|
| Scenarios modeled pre-trade | 2–3 | 20+ simultaneously |
| Signal sources synthesized | 3–5 sequentially | 15+ in parallel |
| Time to full analysis | 2–4 hours | 15–30 minutes |
| Backtesting per setup | Often skipped | Systematic on every trade |
| Risk management | Self-discipline (fails under pressure) | Hard constraints at CTO level (cannot be overridden) |

### Critical Architecture Note — Risk Management

The risk management agent sits at the CTO level and enforces position limits and drawdown rules as HARD CONSTRAINTS that worker agents cannot override. This is architecturally different from every other use case where the CTO synthesizes recommendations. In trading, the CTO is a circuit breaker. If max drawdown is hit, all new positions are blocked regardless of how compelling the workers' analysis looks.

### Required Infrastructure Beyond Claude Commander

- Brokerage API integration layer (connector for Interactive Brokers, Alpaca, or Tastytrade)
- Historical backtesting infrastructure with replay capability
- Real-time market data feed

---

## Priority Ranking

Ranked by near-term revenue potential multiplied by implementation feasibility.

| Rank | Use Case | Revenue Potential | Why This Rank |
|------|----------|------------------|---------------|
| 1 | SEM Sentinel Integration | Fastest path — product exists | Existing product, existing clients, parallel = speed multiplier |
| 2 | Competitive Intelligence | $1.8–3M ARR | Clearest SaaS model, recurring revenue, broadest market |
| 3 | Legal Discovery | $1.5–2.25M ARR | High per-engagement value, clear buyer pain |
| 4 | Prediction Markets | $600K–1.2M ARR + trading profits | Fastest feedback loop, lowest capital requirement |
| 5 | Options/Quant Trading | Trading profits + $720K–1.8M ARR signal service | Real edge exists, requires brokerage integration and backtesting infra |
| 6 | M&A Due Diligence | $1.5–2.5M ARR | Highest per-deal value, needs domain expert co-founder |
| 7 | Medical Literature Synthesis | $1.2–1.6M ARR | High margins, FDA audit trail is byproduct, long sales cycle |
| 8 | Pharma Regulatory | $1.5–2.25M ARR+ (grows to $10M+) | Highest ceiling, longest sales cycle, highest barrier to entry |

---

*Document version: 2026-03-22*
